Form 8-K - Current report:
SEC Accession No. 0001564590-20-042033
Filing Date
2020-08-31
Accepted
2020-08-31 17:10:35
Documents
3
Period of Report
2020-08-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abio-8k_20200829.htm 8-K 32053
2 EX-10.1 abio-ex101_7.htm EX-10.1 329054
3 GRAPHIC g0f3ejsl0tny000001.jpg GRAPHIC 14524
  Complete submission text file 0001564590-20-042033.txt   382580
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 201152295
SIC: 2835 In Vitro & In Vivo Diagnostic Substances